Brussels, Belgium, September 5-9, 2010

ISMC 2010 was organised by the Medicinal Chemistry Divisions of the "Société Royale de Chimie (SRC)" and the "Koninklijke Vlaamse Chemische Vereniging (KVCV)", on behalf of the European Federation for Medicinal Chemistry.

ISMC 2010 continued the tradition established by these biennial International Symposia and covered drug discovery advances in all major therapeutic areas, as well as the most recent advances in lead identification and optimization strategies, in drug design and development, and in prediction of activity as well as of adverse effects. An emphasis was on first time disclosures, emerging drugs and emerging technologies, including nanatechnologies and the chemical modulation of stem cells. ISMC 2010 also illustrated the impact of the omics and biomarker area on the interfaces between chemistry, informatics, biology and experimental medicine.

Vienna, Austria, August 31 - September 4, 2008

The Symposium will focus on important new scientific and technological developments in the drug discovery process; particularly those relevant to medicinal chemistry. The meeting will create an environment for in-depth, informed discussions highlighting the importance of medicinal chemistry in the pharmaceutical industry, academia and drug research. It will also provide opportunities to re-emphasise the crucial position of medicinal chemistry in the drug discovery process and its pivotal role in linking and exploiting the associated biological sciences. Therefore, ISMC-2008 intends to create a forum for all scientists interested in medicinal chemistry and related fields.

Organised by: Austrian Chemical Society

Istanbul, Turkey, August 29 - September 2, 2006

The Symposium will focus on important new scientific and technological developments in the drug discovery process; particularly those relevant to medicinal chemistry. The meeting will create an environment for in-depth, informed discussions highlighting the importance of medicinal chemistry in the pharmaceutical industry, academia and drug research. It will also provide opportunities to re-emphasise the crucial position of medicinal chemistry in the drug discovery process and its pivotal role in linking and exploiting the associated biological sciences. Therefore, the ISMC-2006 intends to create a forum for all scientists interested in medicinal chemistry and related fields.

Organised by: Turkish Association of Pharmaceutical and Medicinal Chemistry

Copenhagen, Denmark & Malmoe, Sweden, August 15-19, 2004

The XVIIth ISMC will reflect that medicinal chemistry is a scientific discipline undergoing rapid development. The molecular biological revolution, new drug design technologies and the progressing mapping of the human genome have created a new exciting working field for scientists in these research areas. These developments are continuously broadening the borderlands between chemistry, informatics and biology and provide new opportunities for drug design on a rational basis. The ISMC 2004 will illustrate the integration of the complementary industrial and academic drug design  approaches.

Organised by: Danish Society for Pharmacology and Toxicology and Swedish Academy of Pharmaceutical Sciences

Barcelona, Spain, September 1-5, 2002

The Symposium will be especially focussed on the following topics:
- New methods and technologies in drug discovery
- Development of chemical libraries
- Early ADMET assessment
- Special topics in organic chemistry oriented to drug development

Organised by: Sociedad Española de Química Terapéutica

Bologna, Italy, September 18-22, 2000

Main topics inlcude:
- Antihypertensive Agents
- The Impact of Organic Chemistry on Drug Discovery
- Antiinfective Agents
- Hypolipidemics/Antiatherosclerotics
- Anticancer Agents

Organised by: Italian Chemical Society - Division of Medicinal Chemistry

Edinburgh, Scotland, September 1998

The scientific sessions will include 8 plenary lectures, and 52 invited lectures running in 3 parallel sessions, and  poster sessions.

The following themes will be included in the coverage
- New Technologies for Drug Discovery
- Ion Channels
- Intracellular Signalling
- Glycine Antagonists
- Predicting DMPK
- Growth Factors
- Glycochemistry and Glycobiology
- 7TM Receptors
- Protease Inhibition

Organised by: Biological and Medicinal Chemistry Sector of the Industrial Division

Maastricht, The Netherlands, September 8-12, 1996

Major topics are:
- Methodology and Design in Medicinal Chemistry
- The Genome as Target for Drug Design
- Enzymes and Enzyme-inhibitors
- CNS agents
- Antibacterial and Antifungal Drug Discovery

Organised by: La Société Royale de Chimie, Division Pharmacochemistry of the Royal Netherlands Chemical Society, Belgian Society for Pharmaceutical Sciences

The complete list of previous ISMC's is available on the EFMC History page.